<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T00:41:14Z</responseDate>
  <request identifier="oai:figshare.com:article/34054083" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34054083</identifier>
        <datestamp>2026-10-02T04:42:08Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>portal_81</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Additional file 2 of Alzheimer’s disease polygenic risk, APOE ε4 dose, and accelerometer-derived circadian rest–activity rhythms in relation to incident dementia and Alzheimer’s disease in UK Biobank: a prospective cohort study</dc:title>
          <dc:creator>Simin Yang (6079499)</dc:creator>
          <dc:creator>Xiong Xiao (1516009)</dc:creator>
          <dc:creator>Yuqian Yang (5561879)</dc:creator>
          <dc:creator>Yinqian Cai (25162200)</dc:creator>
          <dc:creator>Yuxi Zou (504653)</dc:creator>
          <dc:creator>Yanping Tang (191977)</dc:creator>
          <dc:creator>Huihan Ma (11578373)</dc:creator>
          <dc:creator>Zelin Lai (8976176)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>Alzheimer’s disease</dc:subject>
          <dc:subject>Polygenic risk score</dc:subject>
          <dc:subject>APOE</dc:subject>
          <dc:subject>Accelerometry</dc:subject>
          <dc:subject>Circadian rhythm</dc:subject>
          <dc:subject>Incident dementia</dc:subject>
          <dc:description>Additional file 2: Supplementary Tables S1–S9. Description: Multiple-testing results, genotype-category sensitivity analyses, ancestry restriction analyses, diagnostics, full Cox outputs, ICD-10 code lists, incident interaction analyses, mutual-adjustment sensitivity analyses, and the comparison of accelerometry-included versus excluded participants referenced in the main text. Table S1. Multiple-testing results for IS/IV. Raw p values with Bonferroni and BH-FDR corrections across 8 prespecified tests. Table S2. APOE genotype-category sensitivity analysis. Cross-sectional models comparing ε2/4, ε3/4, and ε4/4 groups with non-carriers, plus analyses excluding ε2/4. Table S3. European-only cross-sectional models. Regression outputs restricted to ancestry_group = 1. Table S4. IS/IV model diagnostics. Dropped covariates and diagnostics under QC ≥ 240 30-min bins. Table S5. Full Cox model outputs. Fully adjusted Cox outputs for incident dementia and incident Alzheimer’s disease. Table S6. ICD-10 code lists. Codes used for dementia and Alzheimer’s disease definitions (broad and strict). Table S7. Incident interaction analyses. Fully adjusted Cox models for RA × AD-PRS and RA × APOE ε4 dose in incident dementia and broad Alzheimer’s disease; all interaction p values are nominal. Table S8. Mutual-adjustment sensitivity analysis. Cross-sectional models including both AD-PRS and APOE ε4 dose for RA and phase-timing outcomes. Table S9. Accelerometry subcohort comparison. Baseline comparison of participants included in versus excluded from the accelerometry analytic cohort, used for the inverse-probability-weighted selection analysis.</dc:description>
          <dc:date>2026-06-01T05:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.34054083.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Additional_file_2_of_Alzheimer_s_disease_polygenic_risk_APOE_4_dose_and_accelerometer-derived_circadian_rest_activity_rhythms_in_relation_to_incident_dementia_and_Alzheimer_s_disease_in_UK_Biobank_a_prospective_cohort_study/34054083</dc:relation>
          <dc:rights>CC BY</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
